Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors
July 03, 2023 07:00 ET
|
Renalytix plc
LONDON and SALT LAKE CITY, July 03, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), the first company to commercialize an FDA approved artificial intelligence (AI) enabled...
Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients
June 21, 2023 08:19 ET
|
Biomerica, Inc.
Patent Claims Describe a Novel System to Predict and Help Prevent Adverse Food Reactions Using Personal Medical DataThe Patent further describes Algorithms to help Determine Safety Levels of Food...
Blood Testing Equipment Market Size, Share, and Analysis, By Product, By Method, By End-use and Regional Forecasts, 2022-2032.
May 26, 2023 09:08 ET
|
ReportLinker
New York, May 26, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Blood Testing Equipment Market Size, Share, and Analysis, By Product, By Method, By End-use and...
inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology
May 18, 2023 08:19 ET
|
Biomerica, Inc.
Gastro Health, a leading gastroenterology group, plans to utilize this simplified blood collection method when recommending the inFoods® IBS to their patients Biomerica also announced that inFoods®...
Global Breast Cancer Screening Market will reach US$ 2.12 Billion in 2028
April 25, 2023 10:38 ET
|
ReportLinker
New York, April 25, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Breast Cancer Screening Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share,...
Global Rapid Medical Diagnostic Kits Market to Reach $18.9 Billion by 2030
April 18, 2023 06:00 ET
|
ReportLinker
New York, April 18, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Rapid Medical Diagnostic Kits Industry" -...
Biomerica’s inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).
April 17, 2023 07:47 ET
|
Biomerica, Inc.
Gastro Health is a leading gastroenterology group with over 380 GI physicians in the United StatesClinical study results show patients who eliminated foods as determined by the inFoods® IBS test...
Biomerica Reports Q3 Fiscal 2023 Results
April 14, 2023 16:48 ET
|
Biomerica, Inc.
For the nine months ended February 28, 2023 vs. the same period in 2022, revenues, excluding sales of Covid-related products, increased by 16%.InFoods® IBS Laboratory Developed Test (LDT) validation...
Blood Testing Market to Reach USD 218.2 Bn by 2032 Growing at a 9.6% CAGR | TMR Study
April 14, 2023 12:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, April 14, 2023 (GLOBE NEWSWIRE) -- The blood testing market was valued at USD 80.2 Bn in 2021 and the global market is anticipated to reach USD 218.2 Bn....
Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed
March 08, 2023 08:19 ET
|
Biomerica, Inc.
InFoods® IBS LDT validation testing at the CLIA Lab is completed and the product is now being offered commerciallyClinical trial data shows InFoods® IBS treatment diet significantly improved several...